Christie M. Ballantyne

机构：Manpower Demonstration Research Corporation, Baylor College of Medicine · ORCID：0000-0002-6432-1730

发表论文 2035 篇 · 总被引 127305 次 · h-index 162

代表论文

• Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial (2025 · The Lancet Diabetes & Endocrinology · 被引 20)
• Human plasma proteomic profile of clonal hematopoiesis (2025 · Nature Communications · 被引 7)
• Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials (2026 · American Journal of Preventive Cardiology · 被引 3)
• Proteomics Analysis of Plasma for Risk of Sepsis: Findings from the Atherosclerosis Risk in Communities Study (2025 · The Journal of Applied Laboratory Medicine · 被引 3)
• Proteomic analysis identifies lipoprotein(a)-associated proteins linked to incident atherosclerotic cardiovascular disease events (2025 · medRxiv · 被引 2)
• Real-World Adherence and Effectiveness of Inclisiran in Lowering LDL-C: Results from 1 Year of Follow-Up (2025 · Cardiology and Therapy · 被引 2)